Clinical Trials Browser

Phase 2 × Rectal Cancer Patients × camrelizumab × Clear all

NCT07521605 2026-04-13

Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Rectal Cancer Patients